Works matching IS 10870156 AND DT 2011 AND VI 29 AND IP 2
Results: 36
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 154, doi. 10.1038/nbt.1733
- By:
- Publication type:
- Article
A TALE nuclease architecture for efficient genome editing.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 143, doi. 10.1038/nbt.1755
- By:
- Publication type:
- Article
Learning from (others') experience.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
A mucosal gateway for vaccines.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Industry gives cautious welcome to NIH translational center.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 91, doi. 10.1038/nbt0211-91
- By:
- Publication type:
- Article
The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 129, doi. 10.1038/nbt.1765
- By:
- Publication type:
- Article
Natural-born eaters.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 103, doi. 10.1038/nbt.1770
- By:
- Publication type:
- Article
Cephalon splashes out on mesenchymal stem cells.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 97, doi. 10.1038/nbt0211-97a
- By:
- Publication type:
- Article
Fabry drug march-in denied.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 97, doi. 10.1038/nbt0211-97b
- By:
- Publication type:
- Article
China calling.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 89, doi. 10.1038/nbt.1784
- Publication type:
- Article
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 149, doi. 10.1038/nbt.1775
- By:
- Publication type:
- Article
Regulation of transcription by unnatural amino acids.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 164, doi. 10.1038/nbt.1741
- By:
- Publication type:
- Article
ReNeuron and StemCells get green light for neural stem cell trials.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 95, doi. 10.1038/nbt0211-95
- By:
- Publication type:
- Article
David Roos.
- Published in:
- 2011
- By:
- Publication type:
- Interview
MutaDATABASE: a centralized and standardized DNA variation database.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 117, doi. 10.1038/nbt.1772
- By:
- Publication type:
- Article
Fourth-quarter biotech job picture.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 169, doi. 10.1038/nbt.1778
- By:
- Publication type:
- Article
Gene therapy finds its niche.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 121, doi. 10.1038/nbt.1769
- By:
- Publication type:
- Article
Trade secrets in balance as agencies issue new transparency rules.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 98, doi. 10.1038/nbt0211-98
- By:
- Publication type:
- Article
Mobile vaccine factories.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 99, doi. 10.1038/nbt0211-99b
- By:
- Publication type:
- Article
The 2010 Eurobarometer on the life sciences.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 113, doi. 10.1038/nbt.1771
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 170, doi. 10.1038/nbt.1781
- Publication type:
- Article
Synthetic biology go ahead.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 92, doi. 10.1038/nbt0211-92
- By:
- Publication type:
- Article
RNAi momentum fizzles as pharma shifts priorities.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 93, doi. 10.1038/nbt0211-93
- By:
- Publication type:
- Article
Something new under the skin.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 107, doi. 10.1038/nbt.1768
- By:
- Publication type:
- Article
Sequencing for the cream of the crop.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 138, doi. 10.1038/nbt.1756
- By:
- Publication type:
- Article
Research highlights.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 140, doi. 10.1038/nbt.1786
- By:
- Publication type:
- Article
Testing times for gene test regulators.
- Published in:
- 2011
- Publication type:
- Editorial
Balancing open source stem cell science with commercialization.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 115, doi. 10.1038/nbt.1773
- By:
- Publication type:
- Article
Drug pipeline: Q410.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 101, doi. 10.1038/nbt.1776
- By:
- Publication type:
- Article
Recent patent applications in synthetic biology.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 134, doi. 10.1038/nbt.1782
- Publication type:
- Article
TALEs of genome targeting.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 135, doi. 10.1038/nbt.1767
- By:
- Publication type:
- Article
First public-private vaccine.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 99, doi. 10.1038/nbt0211-99a
- By:
- Publication type:
- Article
Efficient mucosal vaccination mediated by the neonatal Fc receptor.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 158, doi. 10.1038/nbt.1742
- By:
- Publication type:
- Article
Imperial's £140 million boost.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 96, doi. 10.1038/nbt0211-96b
- By:
- Publication type:
- Article
Germany caps drug prices.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 96, doi. 10.1038/nbt0211-96a
- By:
- Publication type:
- Article
2010-bumper year for big biotech.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 2, p. 102, doi. 10.1038/nbt.1777
- By:
- Publication type:
- Article